Keyphrases
Adhesion Proteins
33%
Antibody Inhibition
33%
Autoantibodies
33%
Autoimmune Blistering Diseases
100%
B-cell Depletion
33%
Bench to Bedside
100%
Blister
33%
Cell Signaling
33%
Clinical Evidence
33%
Complement Inhibition
33%
Emerging Treatments
33%
Epidermis
33%
Epidermolysis Bullosa Acquisita
33%
Erosion Types
33%
Inhibitory Monoclonal Antibody
33%
Loss of Tolerance
33%
Mouse Model
33%
Mucous Membrane
33%
Novel Therapeutics
33%
Pathophysiology
33%
Pemphigoid
33%
Pemphigus
33%
Regulatory T (Treg) Cells
33%
Repletion
33%
Signal Transduction Inhibitors
33%
Skin Membrane
33%
Small Molecule Inhibitors
33%
Subepidermal
33%
Systemic Immunosuppression
33%
Therapeutic Target
100%
Traditional Therapy
33%
Treatment Paradigms
33%
Immunology and Microbiology
Autoantibodies
100%
B Cell
100%
Complement Inhibition
100%
Immunosuppression
100%
Monoclonal Antibody
100%
Mouse Model
100%
Mucosa
100%
Pemphigoid
100%
Pemphigus
100%
Regulatory T Cell
100%
Signal Transduction
100%
Medicine and Dentistry
Adhesion Protein
25%
Autoantibodies
25%
B Cell
25%
Blister
25%
Complement Inhibition
25%
Disease
100%
Emerging Treatment
25%
Epidermolysis Bullosa Acquisita
25%
Immunosuppressive Treatment
25%
Monoclonal Antibody
25%
Mucosa
25%
Pathophysiology
25%
Pemphigoid
25%
Pemphigus
25%
Regulatory T Cell
25%
Signal Transduction
25%
Pharmacology, Toxicology and Pharmaceutical Science
Autoantibodies
25%
Blister
25%
Disease
100%
Epidermolysis Bullosa Acquisita
25%
Monoclonal Antibody
25%
Mouse Model
25%
Pathophysiology
25%
Pemphigoid
25%
Pemphigus
25%